gentamicin and Cronobacter Infections studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Research Excerpts

Excerpt	Relevance	Reference
"Intraventricular gentamicin therapy in infants with gram-negative enteric bacillary meningitis and ventriculitis is associated with increased mortality."	9.06	Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. ( McCracken, GH; Mertsola, J; Mustafa, MM; Ramilo, O; Risser, RC; Sáez-Llorens, X, 1989)
"The efficacy and safety of amikacin in treatment of patients with urinary tract infections were evaluated."	9.04	Amikacin Therapy of Urinary tract infections. ( Cox, CE, 1976)
" The purposes of this study were to investigate the clinical efficacy of gentamicin as an initial empirical antimicrobial agent and to evaluate the effects of gentamicin resistance on clinical outcomes in women with complicated non-obstructive acute pyelonephritis (APN)."	7.80	Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. ( Chang, UI; Kim, HW; Wie, SH, 2014)
"To measure the incidence of ampicillin-resistant uropathogens in acute antepartum pyelonephritis and to determine if patients with resistant organisms had different clinical outcomes."	7.74	Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. ( Greer, LG; Hill, JB; Mcintire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD, 2008)
"In a case of metastatic Gram-negative endophthalmitis caused by Serratia marcescens, the bacterial isolate was resistant to gentamicin sulfate and tobramycin but sensitive to amikacin sulfate, a new semisynthetic aminoglycoside approved for systemic use."	7.66	Gentamicin-resistant Serratia marcescens endophthalmitis. ( Gammon, JA; Joseph, P; Schwab, I, 1980)
"30 urological patients with normal renal function were treated with netilmicin because of urinary tract infections, mostly recurrent and due to predisposing factors."	7.66	Netilmicin in urinary tract infections. ( Johnsen, NJ; Lund, F; Svare, J; Thomsen, J; Vejlsgaard, R; Vesterhauge, S, 1980)
"Ampicillin resistance was mainly found in very low and low birthweight infants with late-onset infections, in which aerobic Gram-negative rods were common pathogens."	5.28	Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. A retrospective evaluation of 12 years' experience. ( Larsson, P; Tessin, I; Thiringer, K; Trollfors, B, 1991)
"Gentamicin was found to penetrate poorly into the CSF, reaching mean peak levels of 0."	5.25	Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis. ( Goitein, K; Michel, J; Sacks, T, 1975)
"1% gentamicin cream is not an effective alternative to reduce significant bacteriuria and prevent urinary infection in patients who undergo clean intermittent catheterization."	5.16	[Clean vesical intermittent catheterization: lubrication of vesical catheter through lidocaine or gentamicine?]. ( Liotta, RF; Tarantino, ML, 2012)
"One hundred and eighty-nine patients with acute cholecystitis or cholangitis requiring antibacterial therapy and surgery were randomly allocated in a prospective open study to receive either iv or oral pefloxacin (800 mg per day) or a combination of iv or oral ampicillin (4 g per day) and gentamicin (240 mg per day im)."	5.06	Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections. ( Chacon, JP; Criscuolo, PD; Ferraro, JR; Kobata, CM; Reis, C; Saad, SS, 1990)
"Intraventricular gentamicin therapy in infants with gram-negative enteric bacillary meningitis and ventriculitis is associated with increased mortality."	5.06	Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. ( McCracken, GH; Mertsola, J; Mustafa, MM; Ramilo, O; Risser, RC; Sáez-Llorens, X, 1989)
"Eighteen institutions collaborated in evaluating the comparative efficacy of combined ampicillin and gentamicin therapy with and without intrathecal administration of gentamicin on the clinical and bacteriologic responses of 117 infants with meningitis caused by gram-negative enteric bacteria."	5.04	A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. ( McCracken, GH; Mize, SG, 1976)
"The efficacy and safety of amikacin in treatment of patients with urinary tract infections were evaluated."	5.04	Amikacin Therapy of Urinary tract infections. ( Cox, CE, 1976)
" This protocol would have been appropriate in 85% of all neutropenic bacteremia episodes and 89% of episodes in febrile neutropenia patients compared with piperacillin/tazobactam (79%, P = 0."	3.88	Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia. ( Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J, 2018)
" Thus, on suspicion of sepsis, empiric antibiotic treatment combining piperacillin, oxacillin and gentamicin can be proposed until identification of the causative microorganism is available."	3.80	Epidemiological and bacteriological profiles in children with burns. ( Ben Khalifa, S; Daiki, M; Fekih Hassen, A, 2014)
" The purposes of this study were to investigate the clinical efficacy of gentamicin as an initial empirical antimicrobial agent and to evaluate the effects of gentamicin resistance on clinical outcomes in women with complicated non-obstructive acute pyelonephritis (APN)."	3.80	Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. ( Chang, UI; Kim, HW; Wie, SH, 2014)
"To measure the incidence of ampicillin-resistant uropathogens in acute antepartum pyelonephritis and to determine if patients with resistant organisms had different clinical outcomes."	3.74	Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. ( Greer, LG; Hill, JB; Mcintire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD, 2008)
"In a case of metastatic Gram-negative endophthalmitis caused by Serratia marcescens, the bacterial isolate was resistant to gentamicin sulfate and tobramycin but sensitive to amikacin sulfate, a new semisynthetic aminoglycoside approved for systemic use."	3.66	Gentamicin-resistant Serratia marcescens endophthalmitis. ( Gammon, JA; Joseph, P; Schwab, I, 1980)
"30 urological patients with normal renal function were treated with netilmicin because of urinary tract infections, mostly recurrent and due to predisposing factors."	3.66	Netilmicin in urinary tract infections. ( Johnsen, NJ; Lund, F; Svare, J; Thomsen, J; Vejlsgaard, R; Vesterhauge, S, 1980)
"Treatment with vancomycin and aztreonam was associated with a rapid quantitative reduction in faecal colonisation with enterobacteriaceae, whereas there was no quantitative reduction in colonisation with enterobacteriaceae associated with treatment with vancomycin and gentamicin."	2.67	Enterobacteriaceae and neonatal necrotising enterocolitis. ( Langdale, V; Levene, M; MacKay, P; Martin, C; Millar, MR, 1992)
"Metronidazole was given to both groups as a 500 mg intravenous infusion tid."	2.67	A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group. ( , 1990)
"Amikacin (BB-K8) is a semisynthetic derivative of kanamycin which is active in vitro against many gentamicin-resistant Gram-negative bacilli."	2.64	Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. ( Bartlett, JG; Gorbach, SL; Louie, TJ; Tally, FP; Weinstein, WM, 1975)
"Indications, side effects, dosage and several pharmacokinetic properties of gentamicin, tobramycin, sisomicin, kanamycin, amikacin, and streptomycin are delt with in the first part."	2.35	[Aminoglycoside antibiotics from clinical viewpoint]. ( Lüthy, R, 1975)
"Oral gentamicin was administered to 20 of 62 patients."	1.72	Effectiveness of selective digestive decolonization therapy using oral gentamicin for eradication of carbapenem-resistant Enterobacteriaceae carriage. ( Jung, J; Lee, JS; Lee, SH; Oh, J; Park, SY, 2022)
"Ciprofloxacin resistance has risen fairly quickly in the last four years from 1% to 8%."	1.42	Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy? ( Brair, A; Gray, J; Toozs-Hobson, P, 2015)
"5% of the strains for meropenem combination with tigecycline."	1.39	Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model. ( Labrou, M; Manousaka, S; Michail, G; Pitiriga, V; Pournaras, S; Sakellaridis, N; Tsakris, A, 2013)
"We report a case of retropharyngeal abscess which revealed diabetes mellitus."	1.35	[Retropharyngeal abscess revealing diabetes: a case report]. ( Aderdour, L; Droussi, H; Elfakiri, MM; Hassani, R; Maliki, O; Nejmi, H; Raji, A; Samkaoui, MA; Sassi, A; Younous, S, 2008)
"We report a pneumonia in a patient with chronic renal failure, who had chronic rejection of transplanted kidney."	1.33	A case of pneumonia caused by Ewingella americana in a patient with chronic renal failure. ( Ha, JS; Jeon, DS; Kim, HC; Kim, JR; Ryoo, NH, 2005)
"ENTB bacteremia was successfully treated without CVC removal in 85% of 13 LR-CVC cases with 1 day of bacteremia in contrast to 24% of 25 LR-CVC cases with >1 day of bacteremia (relative risk: 3."	1.32	Central venous catheter removal versus in situ treatment in neonates with enterobacteriaceae bacteremia. ( Buescher, ES; Karlowicz, MG; Kelly, RE; Nazemi, KJ, 2003)
"Respiratory tract infections were the commonest source of infection, and were associated with ventilator therapy rather than the underlying medical condition."	1.30	Survey of aerobic bacterial infections in paediatric surgical intensive care unit patients. ( Tan, CE; Tan, ML; Yap, KP, 1998)
"An unusual case of psoas abscess complicating one of the earliest performed ileo-anal pouch anastomoses is reported."	1.29	Psoas abscess following ileo-anal pouch surgery. ( Isbister, WH; Sanea, O, 1995)
"Bacteremia was documented in 14 of 156 previously healthy children with temperatures of at least 40."	1.29	Acute fevers of unknown origin in young children in the tropics. ( Abiodun, PO; Akpede, GO; Sykes, RM, 1993)
"Ampicillin resistance was mainly found in very low and low birthweight infants with late-onset infections, in which aerobic Gram-negative rods were common pathogens."	1.28	Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. A retrospective evaluation of 12 years' experience. ( Larsson, P; Tessin, I; Thiringer, K; Trollfors, B, 1991)
" Tobramycin was not very effective, whatever the dosage tested (approximately 6."	1.28	Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. ( Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Fantin, B; Le Conte, P; Le Gallou, F; Lepage, JY; Potel, G; Raza, J, 1991)
" Pharmacokinetic studies in mice showed a linear dose response in serum after the 20 and 50 mg/kg subcutaneous dose and urinary recoveries of administered dose of about 60% in 6 hours."	1.28	L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals. ( Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA, 1989)
"Renal carbuncles have traditionally been treated with surgical drainage and appropriate antibiotic therapy."	1.28	Conservative management of renal carbuncles in children. ( Noe, HN; Whitfield, JD, 1989)
"The efficacies of mezlocillin and ticarcillin, each alone and in combination with gentamicin, in the therapy of experimental left-sided Enterobacter aerogenes endocarditis in rabbits were compared."	1.27	Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis. ( Kobasa, WD; Levison, ME, 1984)
"Amikacin resistance has remained very unusual in all organisms, apart from non-aeruginosa Pseudomonas species."	1.27	Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. ( King, A; Phillips, I; Shannon, K, 1986)
" These results indicate that it is necessary to monitor gentamicin therapy by laboratory assay to ensure adequate dosage and that peak serum concentrations of 8 mug/ml or more are significantly correlated with successful treatment of pneumonia caused by coliforms and Ps."	1.26	Pneumonia caused by coliforms and Pseudomonas aeruginosa. ( Noone, P; Rogers, BT, 1976)
" Gentamicin dosage was increased twice over the next eight days to 6 mg/day."	1.26	Infection in a functioning ventriculoperitoneal shunt treated with intraventricular gentamicin. ( Katz, MD; Rapp, RP; Walsh, JW, 1980)
"Netilmicin was shown to be active against sensitive isolates and those strains with resistance patterns corresponding to the presence of: ANT(2"), ANT(2")+AAC(6'), ANT(4'), APH(2")+AAC(6'), APH(3')-IV and AAC(3)-I modifying enzymes."	1.26	Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results. ( Hare, RS; Moss, EL; Sabatelli, FJ; Schaffer, TW; Waitz, JA, 1980)
" The initial dosage of netilmicin was 200 mg twice a day (2."	1.26	Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report. ( Amirak, ID; Noone, P; Perera, MR, 1980)
"Netilmicin may prove to be a useful agent, particularly for infections due to multiresistant Klebsiella or Serratia, or when prolonged aminoglycoside therapy is required."	1.26	Therapeutic experience with netilmicin. ( Bruce, AW; Chadwick, P; Cooke, TD; Hardy, GJ, 1978)
" A dosage of 75 mg/kg fosfomycin enables serum levels of about 32 mug/ml during 4-5 h, being this level higher to the MIC of all isolated strains of S."	1.26	Antibiotherapy of Serratia marcescens septicemia in children. ( Baquero, F; Cañedo, T; Hortelano, JG; Jara, P; Navarro, M; Rodríguez, A; Scarpellini, A, 1977)
"Amikacin sulfate was administered to 18 patients for the treatment of 19 severe infections."	1.26	Amikacin therapy for serious gram-negative infection. ( Berger, SA; Pollock, AA; Rahal, JJ; Richmond, AS; Simberkoff, MS, 1977)
"Treatment with gentamicin effectively sterilized the lungs of these mice but had no effect on either mortality or extent of the pneumonic process."	1.26	The significance of secondary gram-negative coliform infection of the lungs of mice with influenzal pneumonitis. ( Heath, RB; Yealland, SJ, 1978)
"3 mug/ml; 31 to 47% of the drug was excreted within the 8-h dosage interval."	1.26	Clinico-pharmacological studies of sisomicin in ill children. ( Dugal, R; Hammerberg, S; Marks, MI; Vose, A, 1978)
"Sisomicin was the drug of choice for Ps."	1.26	Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin. ( Bis, W; Jeljaszewicz, J; Kazanowski, A; Kuzniewski, P; Molska, J; Włodarczak, K, 1980)
" Netilmicin appears to be effective and safe in the treatment of aerobic gram-negative infections."	1.26	Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections. ( Buckwold, FJ; Fox, L; Harding, GK; Lank, B; Ronald, AR; Thompson, L, 1979)
"Netilmicin was effective against E."	1.26	Netilmicin: its in vitro activity and synergism with penicillin compounds. ( Roy, I; Thadepalli, H, 1980)
"Gentamicin in combination with cephalothin (Gent-Ceph) or with chloramphenicol (Gent-Chloro) was utilized in the treatment of 55 infections occurring in 49 cancer patients."	1.26	Therapy of infections in neutropenic patients: results with gentamicin in combination with cephalothin or chloramphenicol. ( Bodey, GP; Burgess, MA; Rodriguez, V; Valdivieso, M, 1976)
"A retrospective and a prospective group of 38 and 20 patients respectively were studied with regard to bacterial strains, clinical effect, toxic side effects and serum concentration of gentamicin in severe surgical infections."	1.26	Gentamicin treatment in severe surgical infections--serum levels, interactions, toxicity and efficacy. ( Athlin, L; Domellöf, L; Holm, S, 1981)
"In 1973, a large outbreak of nosocomial infections due to Serratia marcescens began at the Vanderbilt University medical complex, a major characteristic of which was high-level resistance to gentamicin and carbenicillin."	1.26	Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. ( Alford, RH; Farrar, WE; McGee, ZA; Rubens, CE; Schaberg, DR; Schaffner, W, 1981)
" Based on the determination of serum levels of Tobramycin and Amoxycillin in newborns general recommendations for the dosage of these new antibiotics are given."	1.25	[Antibiotics in newborns and young infants]. ( Simon, C, 1975)
"Gentamicin was found to penetrate poorly into the CSF, reaching mean peak levels of 0."	1.25	Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis. ( Goitein, K; Michel, J; Sacks, T, 1975)

Timeframe	Studies, this research(%)	All Research%
pre-1990	164 (71.62)	18.7374
1990's	22 (9.61)	18.2507
2000's	20 (8.73)	29.6817
2010's	22 (9.61)	24.3611
2020's	1 (0.44)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin[NCT05593601]	Phase 4	60 participants (Anticipated)	Interventional	2022-11-24	Recruiting
Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes. A Randomized Prospective, Open Trial[NCT02819570]	Phase 4	400 participants (Anticipated)	Interventional	2015-11-30	Recruiting
A Phase I/II Study to Assess the Safety and Immunogenicity of WT1-A10 + AS01B Antigen-Specific Cancer Immunotherapeutic (ASCI) Combined With Infusions of ex Vivo Regulatory T Cells Depleted T Lymphocytes in in Vivo Regulatory T Cells Depleted Patients as [NCT01513109]	Phase 1/Phase 2	20 participants (Anticipated)	Interventional	2011-12-31	Recruiting
Antibiotic Treatment Versus no Antibiotics in the Postoperative Acute Cholecystitis Low and Moderately Severe[NCT01015417]	Phase 3	414 participants (Actual)	Interventional	2010-05-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Biological Availability; Carbapenem-Resistant Enterobacteriaceae; C	2017
Non-surgical management of thyroid abscess with ultrasound-guided fine-needle application of an antibiotic followed by sclerotization with absolute alcohol. Minerva endocrinologica, 2013, Volume: 38, Issue:3 Topics: Abscess; Adult; Anti-Bacterial Agents; Biopsy, Fine-Needle; Ciprofloxacin; Combined Modality Therapy	2013
Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature. Pharmacotherapy, 2003, Volume: 23, Issue:4 Topics: Cefepime; Cephalosporins; Cerebral Ventricles; Drug Therapy, Combination; Enterobacter cloacae; Ente	2003
[Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)]. Immunitat und Infektion, 1979, Volume: 7, Issue:4 Topics: Air Microbiology; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infectio	1979
[Recent trends in and dangers of gram negative bacillus infections]. Nihon rinsho. Japanese journal of clinical medicine, 1977, Volume: 35, Issue:3 Topics: Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans	1977
[Aminoglycoside antibiotics from clinical viewpoint]. International journal of clinical pharmacology and biopharmacy, 1975, Volume: 11, Issue:2 Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections;	1975
Review of epidemic aminoglycoside resistance worldwide. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Disease Outbreaks; Drug Resist	1986
[Gentamicin resistance in clinical strains of microorganisms: genetic control and biochemical mechanisms of resistance]. Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology, 1985, Volume: 30, Issue:1 Topics: Acetyltransferases; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Klebsiel	1985
The chemotherapy of enterobacterial infections. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1968, Volume: 12 Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Enterobacteriaceae;	1968
Chemotherapy in ear disease. Otolaryngologic clinics of North America, 1972, Volume: 5, Issue:1 Topics: Acute Disease; Child; Child, Preschool; Chlorpheniramine; Chronic Disease; Ear, Middle; Enterobacter	1972
Advances in antibiotics. The Practitioner, 1969, Volume: 203, Issue:216 Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicin	1969
Gentamicin. The Medical clinics of North America, 1970, Volume: 54, Issue:5 Topics: Absorption; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans;	1970

Article	Year
[Clean vesical intermittent catheterization: lubrication of vesical catheter through lidocaine or gentamicine?]. Urologia, 2012, Volume: 79, Issue:1 Topics: Antibiotic Prophylaxis; Asymptomatic Diseases; Bacteriuria; Catheter-Related Infections; Enterobacte	2012
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections. The American journal of medicine, 1983, Aug-29, Volume: 75, Issue:2A Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae Infe	1983
A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection. Clinical therapeutics, 1983, Volume: 5, Issue:5 Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides Infections; Cefoxitin; Clinical Trials as	1983
[Effectiveness of netilmicin in the treatment of urinary tract infections]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Oct-10, Volume: 38, Issue:41 Topics: Adult; Aged; Bacillus subtilis; Bacteriuria; Clinical Trials as Topic; Enterobacteriaceae Infections	1983
A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. The Journal of pediatrics, 1976, Volume: 89, Issue:1 Topics: Ampicillin; Child, Preschool; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia	1976
Amikacin Therapy of Urinary tract infections. The Journal of infectious diseases, 1976, Volume: 134 SUPPL Topics: Adolescent; Adult; Aged; Amikacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Female;	1976
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. Annals of internal medicine, 1975, Volume: 83, Issue:4 Topics: Aged; Amikacin; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae; Enterobact	1975
Enterobacteriaceae and neonatal necrotising enterocolitis. Archives of disease in childhood, 1992, Volume: 67, Issue:1 Spec No Topics: Aztreonam; Drug Therapy, Combination; England; Enterobacteriaceae Infections; Enterocolitis, Pseudom	1992
Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B Topics: Adolescent; Adult; Ampicillin; Cholangitis; Cholecystitis; Drug Therapy, Combination; Enterobacteria	1990
A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Enterobacteriaceae I	1990
Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. The Journal of infectious diseases, 1989, Volume: 160, Issue:5 Topics: Cerebral Ventricles; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Encephalitis; Endotoxins; En	1989
Gentamicin. Clinical and pharmacological studies. Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1970, Volume: 3, Issue:2 Topics: Acinetobacter Infections; Bacteroides Infections; Biliary Tract Diseases; Cellulitis; Clinical Trial	1970
Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli. Current therapeutic research, clinical and experimental, 1971, Volume: 13, Issue:3 Topics: Adolescent; Adult; Aged; Carbenicillin; Clinical Trials as Topic; Drug Synergism; Enterobacteriaceae	1971

gentamicin and Cronobacter Infections

Research Excerpts

Research

Studies (229)

Authors

Clinical Trials (4)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Park, SY	1
Lee, JS	1
Oh, J	1
Lee, SH	1
Jung, J	1
Zavascki, AP	1
Klee, BO	1
Bulitta, JB	1
Kleinhendler, E	1
Cohen, MJ	1
Moses, AE	1
Paltiel, O	1
Strahilevitz, J	1
Cahan, A	1
Weme, ET	1
Hidalgo, L	1
Hopkins, KL	1
Gutierrez, B	1
Ovejero, CM	1
Shukla, S	1
Douthwaite, S	1
Prasad, KN	1
Woodford, N	1
Gonzalez-Zorn, B	1
Kosmidis, C	1
Giannopoulou, M	1
Flountzi, A	1
Markogiannakis, A	1
Goukos, D	1
Petrikkos, G	2
Daikos, GL	2
Tzanetou, K	1
Michail, G	1
Labrou, M	1
Pitiriga, V	1
Manousaka, S	1
Sakellaridis, N	1
Tsakris, A	1
Pournaras, S	1
Halenka, M	1
Fekih Hassen, A	1
Ben Khalifa, S	1
Daiki, M	1
Ollier, V	1
Farfour, E	1
Charara, O	1
Marque Juillet, S	1
Mirand, A	1
Chalouhi, C	1
Foucaud, P	1
Wie, SH	1
Kim, HW	1
Chang, UI	1
Lin, TY	1
Chan, MC	1
Yang, YS	1
Lee, Y	1
Yeh, KM	1
Lin, JC	1
Chang, FY	1
Wolf, MF	1
Miron, D	1
Peleg, D	1
Rechnitzer, H	1
Portnov, I	1
Salim, R	1
Keness, Y	1
Reich, D	1
Ami, MB	1
Peretz, A	1
Koshnir, A	1
Shachar, IB	1
Brair, A	1
Toozs-Hobson, P	1
Gray, J	1
Takahashi, K	1
Uno, S	1
Sada, R	1
Adler, A	1
Sturlesi, N	1
Fallach, N	1
Zilberman-Barzilai, D	1
Hussein, O	1
Blum, SE	1
Klement, E	1
Schwaber, MJ	1
Carmeli, Y	1
Ghotaslou, R	1
Yeganeh Sefidan, F	1
Akhi, MT	1
Asgharzadeh, M	1
Mohammadzadeh Asl, Y	1
Greer, LG	1
Roberts, SW	1
Sheffield, JS	1
Rogers, VL	1
Hill, JB	1
Mcintire, DD	1
Wendel, GD	1
Aderdour, L	1
Hassani, R	1
Nejmi, H	1
Elfakiri, MM	1
Maliki, O	1
Droussi, H	1
Sassi, A	1
Younous, S	1
Samkaoui, MA	1
Raji, A	1
Kang, HY	1
Kim, J	1
Seol, SY	1
Lee, YC	1
Lee, JC	1
Cho, DT	1
Amezyane, T	1
Abouzahir, A	1
El Kharrass, A	1
Bassou, D	1
Fatihi, J	1
Hammi, S	1
Mahassin, F	1
Ghafir, D	1
Ohayon, V	1
Goold, LA	1
Warrier, SK	1
Wittles, NK	1
Nathan, F	1
Ndiaye, M	1
Sène, MS	1
Sow, AD	1
Seck, LB	1
Coulibaly, T	1
Diagne, NS	1
Touré, K	1
Diop, AG	1
Ndiaye, MM	1
Arpin, C	1
Thabet, L	1
Yassine, H	1
Messadi, AA	1
Boukadida, J	1
Dubois, V	1
Coulange-Mayonnove, L	1
Andre, C	1
Quentin, C	1
Liotta, RF	1
Tarantino, ML	1
Galani, I	1
Souli, M	1
Chrysouli, Z	1
Poulakou, G	1
Psichogiou, M	1
Panagea, T	1
Argyropoulou, A	1
Stefanou, I	1
Plakias, G	1
Giamarellou, H	1
Aller, SC	1
Chusid, MJ	1
Nazemi, KJ	1
Buescher, ES	1
Kelly, RE	1
Karlowicz, MG	1
Barnes, BJ	1
Wiederhold, NP	1
Micek, ST	1
Polish, LB	1
Ritchie, DJ	1
Ryoo, NH	1
Ha, JS	1
Jeon, DS	1
Kim, JR	1
Kim, HC	1
Benenson, S	1
Yinnon, AM	1
Schlesinger, Y	1
Rudensky, B	1
Raveh, D	1
Dyachenko, P	1
Ziv, M	1
Kamil, S	1
Dodiuk-Gad, R	1
Chazan, B	1
Rozenman, D	1
Duijkeren, EV	1
Box, AT	2
Schellen, P	1
Houwers, DJ	1
Fluit, AC	2
Díaz, MA	1
Cooper, RK	1
Cloeckaert, A	1
Siebeling, RJ	1
Jones, SL	1
Nguyen, VK	1
Nguyen, TM	1
Athan, E	1
Kilani, B	1
Ammari, L	1
Benaïssa, HT	1
Ben Chaabane, T	1
Fendri, C	1
Dervisoglu, E	1
Yumuk, Z	1
Yegenaga, I	1
Ishibe, K	1
Osatomi, K	1
Hara, K	1
Kanai, K	1
Yamaguchi, K	1
Oda, T	1
Liang, YJ	1
Zhai, XB	1
He, LX	1
Guo, ZL	1
Ren, T	1
He, ZG	1
Zhang, L	1
Zheng, YH	1
Kanee, B	1
Husson, MO	1
Izard, D	1
Bryskier, A	1
Vincent, P	1
Leclerc, H	1
Bourrillon, A	1
Brackman, D	1
Boussougant, Y	1
de Paillerets, F	1
Hart, CA	3
Bullock, DW	1
Bidwell, JL	1
Reeves, DS	1
White, LO	1
Turner, A	1
Speller, DC	2
Wilkinson, PJ	1
Tschäpe, H	1
Bratoeva, M	1
Heier, H	1
Tietze, E	1
Ziesché, K	1
Rishce, H	1
Sattler, FR	1
Hall, S	1
Hanna, CE	1
Green, EA	1
Shlaes, DM	2
Currie, CA	2
Lewis, DA	1
Hawkey, PM	1
Primavesi, RJ	1
Fleming, PJ	1
Pitt, TL	1
Stille, W	1
Bubrick, MP	1
Howard, RJ	1
Pancorbo, S	1
Lorber, RR	1
Chin, TW	1
Yost, R	1
Sato, K	1
Yamashita, K	1
Okachi, R	1
Borówka, A	1
Mészáros, J	1
Krzeski, T	1
Wolnik, Z	1
Jeljaszewicz, J	2
Sculier, JP	1
Coppens, L	1
Klastersky, J	5
Messihi, J	1
Smith, LG	1
Najjar, S	1
Rotter, G	1
Eanes, M	1
Floyd, R	1
Haverkorn, MJ	1
Tanaka, M	1
Kawabata, S	1
Nishino, T	1
Tanino, T	1
Kobasa, WD	2
Kaye, D	2
Betts, RF	1
Valenti, WM	1
Chapman, SW	1
Chonmaitree, T	1
Mowrer, G	1
Pincus, P	1
Messner, M	1
Robertson, R	1
Jarlier, V	1
Philippon, A	1
Nicolas, MH	1
Bismuth, R	1
Paul, G	1
Fusciardi, J	1
Levison, ME	1
Weinstein, RA	1
Nathan, C	1
Gruensfelder, R	1
Kabins, SA	1
Navashin, PS	1
Svare, J	1
Johnsen, NJ	1
Vesterhauge, S	1
Lund, F	1
Thomsen, J	1
Vejlsgaard, R	1
Michalsen, H	1
Halvorsen, K	1
Bergan, T	1
Peitersen, B	1
Hørlyk, H	1
Nielsen, M	1
Prag, J	1
Korner, B	2
Heilesen, AM	1
Friis-Møller, A	1
Perera, MR	1
Amirak, ID	1
Noone, P	2
Waitz, JA	2
Hare, RS	1
Moss, EL	1
Sabatelli, FJ	1
Schaffer, TW	1
Katz, MD	1
Rapp, RP	1
Walsh, JW	1
Gammon, JA	1
Schwab, I	1
Joseph, P	1
Włodarczak, K	1
Bis, W	1
Kazanowski, A	1
Kuzniewski, P	1
Molska, J	1
Schaberg, DR	1
Rubens, CE	1
Alford, RH	3
Farrar, WE	2
Schaffner, W	1
McGee, ZA	2
Athlin, L	1
Domellöf, L	1
Holm, S	1
Gibson, MF	1
Jansen, RD	1
Meadow, WL	1
Schwartz, IK	1
Ogata, ES	1
Thadepalli, H	1
Roy, I	1
Jain, K	1
Prabhakar, K	1
Ayyagiri, A	1
Kumar, L	1
Lacey, SL	1
Want, SV	1
Sanea, O	1
Isbister, WH	1
Balslev, T	2
Kristensen, B	2
Ebbesen, F	2
Schumacher, H	2
Korsager, B	2
Matsui, S	1
de Champs, C	1
Franchineau, P	1
Gourgand, JM	1
Loriette, Y	1
Gaulme, J	1
Sirot, J	1
al Ansari, N	1
McNamara, EB	1
Cunney, RJ	1
Flynn, MA	1
Smyth, EG	1
Akpede, GO	1
Abiodun, PO	1
Sykes, RM	1
De Gheldre, Y	1
Maes, N	1
Rost, F	1
De Ryck, R	1
Clevenbergh, P	1
Vincent, JL	1
Struelens, MJ	1
Holcombe, SJ	1
Schneider, RK	1
Bramlage, LR	1
Embertson, RM	1
Yap, KP	1
Tan, ML	1
Tan, CE	1
Adwan, K	1
Abu-Hasan, N	1
Finnström, O	1
Isaksson, B	1
Haeggman, S	1
Burman, LG	1
Wojciechowska, D	1
Janicka, G	1
Hareńska, K	1
Schønheyder, HC	1
Sanden, AK	1
Sørensen, HT	1
Guichenez, P	1
Oziol, E	1
Joomaye, Z	1
Marciano, J	1
Guichenez, G	1
Ygout, JY	1
Fattal, O	1
Deville, JG	1
Leverstein-van Hall, MA	1
Blok, HE	1
Peters, ED	1
Weersink, AJ	1
Verhoef, J	1
Richmond, AS	2
Simberkoff, MS	3
Rahal, JJ	3
Schaefler, S	1
Meyer, RD	2
Lewis, RP	1
Halter, J	1
White, M	1
Chadwick, P	1
Bruce, AW	1
Cooke, TD	1
Hardy, GJ	1
Hartemann, P	1
Imbs, MA	1
Blech, MF	1
Baquero, F	1
Hortelano, JG	1
Navarro, M	1
Scarpellini, A	1
Jara, P	1
Cañedo, T	1
Rodríguez, A	1
Finland, M	2
Thomas, FE	1
Jackson, RT	1
Melly, A	1
Mashimo, K	1
Rosenthal, E	1
Kohns, U	1
Lackner, F	1
Coraim, F	1
Benzer, H	1
Koller, W	1
Pichler, H	1
Rotter, M	1
Stanek, G	1
Yu, VL	1
Oakes, CA	1
Axnick, KJ	1
Merigan, TC	1
Weingärtner, L	1
Sitka, U	1
Patsch, R	1
Burchardt, U	1
Richter, I	1
Leonard, JM	1
Check, WA	1
Rusthoven, JJ	1
Davies, TA	1
Lerner, SA	1
Pinto, L	1
Di Lena, C	1
Marchi, K	1
Jolascon, A	1
Vitale, R	1
Pollock, AA	1
Berger, SA	1
Yealland, SJ	1
Heath, RB	1
Marks, MI	1
Vose, A	1
Hammerberg, S	1
Dugal, R	1
Trestman, I	1
Parsons, J	1
Santoro, J	1
Goodhart, G	1
Kauffman, CA	1
Ramundo, NC	1
Williams, SG	1
Dey, CR	1
Phair, JP	1
Watanakunakorn, C	1
Edelstein, PH	1
Chua, C	1
Buckwold, FJ	1
Ronald, AR	1
Lank, B	1
Thompson, L	1
Fox, L	1
Harding, GK	1
Kröger, E	1
Rohmann, H	1
Osten, B	1
Falkenhagen, U	1
McCracken, GH	2
Mize, SG	1
Valdivieso, M	1
Bodey, GP	2
Burgess, MA	1
Rodriguez, V	2
Cox, CE	2
Rogers, BT	1
Pardo Zubiris, A	1
Gimeno Blasco, L	1
Andonegui Oteiza, J	1
LeFrock, JL	1
Joseph, BK	1
Klainer, AS	2
Gainer, RB	1
Prince, RA	1
Lincoln, LJ	1
Weinstein, AJ	1
Gallagher, M	1
Abrutyn, E	2
Lee, EL	1
Robinson, MJ	1
Thong, ML	1
Puthucheary, SD	1
Ong, TH	1
Ng, KK	1
Daikos, GK	1
Kosmidis, JC	1
Hamilton-Miller, JM	1
Brumfitt, W	1
Mazzei, T	1
Paradiso, M	1
Nicoletti, I	1
Periti, P	1
Tapper, ML	1
McCarthy, LR	1
Mayo, JB	1
Armstrong, D	1
Grajwer, LA	1
Mukhopadhyay, D	1
Grossman, BJ	1
Simon, C	1
Lüthy, R	1
Tally, FP	1
Louie, TJ	1
Weinstein, WM	1
Bartlett, JG	1
Gorbach, SL	1
Ross, GN	1
Baraff, LJ	1
Quismorio, FP	1
Sanders, CC	1
Sanders, WE	1
Rengachary, SS	1
Kugler, K	1
Watanabe, I	1
Goitein, K	1
Michel, J	1
Sacks, T	1
Le Frock, JL	1
Zuckerman, K	1
Millar, MR	1
MacKay, P	1
Levene, M	1
Langdale, V	1
Martin, C	1
Wade, JJ	1
Desai, N	1
Casewell, MW	1
Tessin, I	1
Trollfors, B	1
Thiringer, K	1
Larsson, P	1
Potel, G	2
Caillon, J	2
Fantin, B	1
Raza, J	1
Le Gallou, F	1
Lepage, JY	1
Le Conte, P	1
Bugnon, D	2
Baron, D	2
Drugeon, H	1
Spritzer, R	1
vd Kamp, HJ	1
Dzoljic, G	1
Sauer, PJ	1
Chacon, JP	1
Criscuolo, PD	1
Kobata, CM	1
Ferraro, JR	1
Saad, SS	1
Reis, C	1
Barg, NL	1
Cooper, JF	1
Popov, AI	1
Grishchuk, VS	1
Vliegenthart, JS	1
Ketelaar-van Gaalen, PA	1
van de Klundert, JA	1
Gilfillan, EC	1
Pelak, BA	1
Weissberger, BA	1
Abruzzo, GK	1
Fromtling, RA	1
Bland, JA	1
Hadley, SK	1
Gadebusch, HH	1
Orsini, JA	1
Benson, CE	1
Spencer, PA	1
Van Miller, E	1
Whitfield, JD	1
Noe, HN	1
Zeiter, JH	1
Koch, DD	1
ParkE, DW	1
Font, RL	1
Mustafa, MM	1
Mertsola, J	1
Ramilo, O	1
Sáez-Llorens, X	1
Risser, RC	1
Adeyeba, OA	1
Mehtar, S	1
Drabu, Y	1
Blakemore, P	1
Lecomte, P	1
Drugeon, HB	1
Mayer, KH	1
Russell, RC	1
Graham, DR	1
Feller, AM	1
Zook, EG	1
Mathur, A	1
Bouza, E	1
van den Ende, J	1
Rotter, ML	1
Mulligan, ME	1
Kettner, M	1
Navarová, J	1
Langsádl, L	1
Phillips, I	2
King, A	1
Shannon, K	1
Barg, N	1
Moyer, R	1
Rolin, O	1
Bouanchaud, DH	1
Belokrysenko, SS	1
Bryan, CS	1
John, JF	1
Pai, MS	1
Austin, TL	1
Abadzhieva, AN	1
Danilenko, VN	1
Navashin, SM	1
Bremner, DA	1
Graybill, JR	1
Marshall, LW	1
Charache, P	1
Wallace, CK	1
Melvin, VB	1
McHenry, MC	1
Hawk, WA	1
Sauer, H	1
Semenitz, E	1
Menardi, G	1
Garrod, LP	1
Wilfert, JN	2
Barrett, FF	2
Ewing, WH	1
Kass, EH	2
Wilkowske, CJ	1
Washington, JA	3
Martin, WJ	2
Ritts, RE	2
Williams, TW	1
Sailer, JE	1
Viroslav, J	1
Knight, V	1
Glasgow, N	1
Moreland, N	1
Birk, RJ	1
Pien, FD	1
Hermans, PE	1
Mariel, C	1
Veyssier, P	1
Péchère, JC	1
Grieco, MH	1
McCray, RS	1
Nay, HR	1
Shackelford, PG	1
Ratzan, SA	1
Shearer, WT	1
Ben-Tovim, T	1
Eylan, E	1
Romano, A	1
Stein, R	1
Mayser, P	1
Schmiedel, A	1
Kernert, B	1
Feigenbaum, JA	1
Stern, WE	1
Chisholm, GD	1
Mathalone, B	1
McAllister, TA	1
Saad, AF	1
Matz, K	1
Götze, W	1
Koperska, K	1
Fedder, J	1
Belfrage, S	1
Banck, G	1
Nordström, L	1
Christensson, P	1
Ekberg, M	1
Denneberg, T	1
Riff, LJ	1
Modde, H	1
Rogala, EJ	1
Cruess, RL	1
Farhoudi, HO	1
Banks, T	1
Ali, N	1
Dorwart, BB	1
Schumacher, HR	1
Shaw, EJ	1
Clark, AD	1
Anderson, FM	1
Elfving, J	1
Pettay, O	1
Sunila, R	1
Pöntynen, S	1
Neguţ, M	1
Szegli, L	1
Răiculescu, M	1
Isom, W	1
Smithivas, T	1
Noriega, ER	1
Holloway, WJ	2
Eykyn, SJ	1
Stratford, BC	2
Dixson, S	1
Holt, RJ	1
Newman, RL	1
Gary, NE	1
Benhassine, M	1
Rahal, K	1
Mered, B	1
Michaeli, D	1
Weinstein, L	1
Swings, G	1
Daneau, D	1
Cappel, R	1
Debusscher, L	1
Bullock, WE	1
Plotkin, SA	1
Middleman, E	1
Umsawasdi, T	1
Irmer, W	1
Urlesberger, H	1
Zechner, E	1
Stephens, JF	1
Black, HR	1
Griffith, RS	1
Rosaschino, F	1
Buonomo, A	1
Rubenfire, M	1
Gass, HH	1
Goldstein, AS	1
Lerner, AM	1